Protein heals wounds, boosts immunity and protects from cancerMay 01, 2012
University of Calgary researcher edits special issue on disease fighting properties of lactoferrin
Hans Vogel, a professor in the biological sciences department, is the guest editor of a special issue of the journal Biochemistry and Cell Biology that focuses on lactoferrin, an important iron-binding protein with many health benefits.
"Some people describe this protein as the 'Swiss army knife' of the human host defense system," says Vogel. "We now know that lactoferrin has many functions in innate immunity and that it plays a role in protecting us from bacterial, viral, fungal, and protozoal infections. It can even protect us from some forms of cancer."
Lactoferrin-which is secreted into human milk, blood and other biofluids-has attracted a lot of interest from academics and industry. Furthermore, Vogel says it's likely the only protein that garners its own regular scientific conference. Researchers are starting to use lactoferrin as a potential therapeutic protein, one that can be taken orally instead of injected like other proteins.
"Lactoferrin is quite an unusual protein that has many effects on health," Vogel says. "It is also used as a general health-promoting substance, and in Japan it is added to infant formula."
The June issue of the journal includes 27 peer reviewed papers from leading international researchers on topics including the role of lactoferrin on small intestinal growth and development during early life, use of bovine lactoferrin to inhibit influenza and how the protein may prevent some preterm deliveries.
The protein may also have an important role in wound healing, says Vogel. "We've been working in this area for about 15 years and it's cool to see how the whole field slowly progresses, and you start to see more and more interesting applications. It is particularly exiting to see that clinical trials are now going on in the infectious disease area and in cancer."
Vogel says being a guest editor was a lot of work and a lot of fun. He also wrote an introductory article for the special issue that provides an overview of the current status of research into the protein. Read the open access article: http://www.nrcresearchpress.com/doi/full/10.1139/o2012-016
If you want to find out more details about lactoferrin you can read the special issue in Biochemistry and Cell Biology, Vol. 90, Issue 3, published by the NRC Research Press: http://nrcresearchpress.com/doi/story/10.4141/news.2012.04.17.66
University of Calgary
Related Lactoferrin Current Events and Lactoferrin News Articles
First synthetic model of bacteria outer membrane
Disease causing bacteria mostly belong to two groups -Gram-positive, which include MRSA, and Gram-negative bacteria which include E. coli (Escherichia coli) and the bacteria behind meningitis and plague.
First synthetic model of a bacterial outer membrane will support antibiotic development
For the first time researchers from Newcastle University and the Science and Technology Facilities Council have produced a working model giving access to unprecedented information about the bacteria which is notoriously hard to study due to its size and complex exterior.
Potent protein heals wounds, boosts immunity and protects from cancer - Special issue on disease fighting properties of lactoferrin
Lactoferrin is an important iron-binding protein with many health benefits. The major form of this powerful protein, is secreted into human biofluids (e.g. milk, blood, tears, saliva), and is responsible for most of the host-defense properties.
Exercising our immune system
Elite athletes - often perceived as the epitome of health and fitness - may be more susceptible to common illness and are therefore proving useful in helping scientists understand more about the immune system.
Vistatec York secures follow-on funding for pioneering 'See & Treat' cancer technology
Vistatec York Ltd, whose groundbreaking technology offers the potential for earlier and more accurate detection and treatment of cancer, has secured follow-on funding from the White Rose Technology Seedcorn Fund (WRTSF). The company has also announced the appointment of James Spearman to the position of Chief Executive Officer. This latest funding brings WRTSF's total investment in Vistatec to just over £400,000. Vistatec's technology is based on the research of Paul Walton, Professor of Bioinorganic Chemistry at the University of York. His work at the forefront of molecular imaging has resulted in a new method of locating and diagnosing cancer, which harnesses the tumour targeting pro
Nature press release 30 May issue
 LIFELINES: SNOT, SWEAT AND TEARS BREAK BIOFILMS (pp552-555)
More Lactoferrin Current Events and Lactoferrin News Articles